Statin safety and drug interactions: clinical implications

MB Bottorff - The American journal of cardiology, 2006 - Elsevier
The risks of muscle adverse events related to use of the 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors, or statins, increase significantly with the …
被引用次数：251 相关文章

[引用][C] Statin Safety and Drug Interactions: Clinical Implications

MB Bottorff - The American Journal of Cardiology, 2006 - cir.nii.ac.jp

Statin Safety and Drug Interactions: Clinical Implications

MB Bottorff - American Journal of Cardiology, 2006 - ajconline.org
The risks of muscle adverse events related to use of the 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors, or statins, increase significantly with the …

Statin Safety and Drug Interactions: Clinical Implications

MB Bottorff - The American Journal of Cardiology, 2006 - infona.pl
The risks of muscle adverse events related to use of the 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors, or statins, increase significantly with the …

Statin safety and drug interactions: clinical implications

MB Bottorff - The American journal of cardiology, 2006 - pubmed.ncbi.nlm.nih.gov
The risks of muscle adverse events related to use of the 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors, or statins, increase significantly with the …

Statin safety and drug interactions: clinical implications.

MB Bottorff - The American Journal of Cardiology, 2006 - europepmc.org
The risks of muscle adverse events related to use of the 3-hydroxy-3-methylglutaryl
coenzyme A (HMG-CoA) reductase inhibitors, or statins, increase significantly with the …